Skip to main content
. 2024 Dec 3;111(12):znae298. doi: 10.1093/bjs/znae298

Table 3.

Final priority outcomes of pelvic exenteration, which met ‘consensus in’ criteria among patient, carer, and clinician stakeholder groups

Priority outcome Lay description Patients (n = 21) Carers (n = 4) Clinicians (n = 116) Combined rank
Median Rank Median Rank Median Rank
Survival
 Overall survival The length of time until death from any cause (including cancer and non-cancer causes) 90.0 1 77.5 9 85.0 2 3
 Disease-free survival The length of time a person lives without cancer coming back 89.0 2 88.5 5 80.0 5 4
 Local recurrence-free survival The length of time a person lives without cancer coming back in the pelvis 86.0 6 91.0 3 85.0 2 2
Cancer recurrence
 Distant recurrence The cancer coming back elsewhere in the body, other than the pelvis 83.0 9 94.5 1 70.0 8 8
Patient-reported outcomes and functioning
  Psychological functioning Ability to think, reason, remember, and make decisions, as well as experience and cope with emotions, including fear of the cancer coming back 84.0 8 80.5 8 76.0 7 9
 Physical functioning Ability to perform daily activities, such as walking, climbing stairs, and carrying out self-care tasks 87.0 5 88.0 6 80.0 5 5
 Global quality of life Overall well-being, including physical health, emotional well-being, social relationships, and life satisfaction 85.0 7 81.5 7 85.0 2 5
 Mobility Being able to walk or get around 88.0 3 90.5 4 70.0 9 5
Pathological outcomes
 Resection margins Surgical removal of the entire tumour in one piece, with clear margins 88.0 3 92.5 2 90.0 1 1

The median score of relative importance and corresponding rank for each stakeholder group is presented, as well as the combined rank.